Showing results (981-990 of 7,009) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 26, 2015
ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?Florence Vergne, Gilles Quéré, Sophie Andrieu-Key, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Changing costs of metastatic non small cell lung cancer in the NetherlandsW R Keusters, V A de Weger, A Hövels, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Genetic predisposition to lung adenocarcinoma among never-smoking Chinese with different epidermal growth factor receptor mutation statusLi Han, Cheuk-Kwong Lee, Herbert Pang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?Bo Zhang, Jianlin Xu, Xueyan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancerJean-Paul Sculier, Jean-Jacques Lafitte, Thierry Berghmans, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapyByung Jo Park, Jong Ho Cho, Jung Hee Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsyR Minari, P Bordi, M Del Re, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicinYosuke Miura, Kyoichi Kaira, Reiko Sakurai, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumabKoichi Sato, Hiroaki Akamatsu, Eriko Murakami, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysisSaad A Khan, Sandi L Pruitt, Lei Xuan, et al.
Pageof 701